Aurobindo Pharma Limited (BOM:524804)

Aurobindo Pharma Statistics

Total Valuation

BOM:524804 has a market cap or net worth of INR 707.18 billion. The enterprise value is 696.13 billion.

Market Cap	707.18B
Enterprise Value	696.13B

Important Dates

The next estimated earnings date is Saturday, February 14, 2026.

Earnings Date	Feb 14, 2026
Ex-Dividend Date	Aug 8, 2025

Share Statistics

Current Share Class	580.80M
Shares Outstanding	n/a
Shares Change (YoY)	-0.58%
Shares Change (QoQ)	-0.01%
Owned by Insiders (%)	15.22%
Owned by Institutions (%)	51.81%
Float	278.91M

Valuation Ratios

The trailing PE ratio is 20.66 and the forward PE ratio is 17.48.

PE Ratio	20.66
Forward PE	17.48
PS Ratio	2.17
PB Ratio	2.02
P/TBV Ratio	2.31
P/FCF Ratio	19.52
P/OCF Ratio	11.49
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.58, with an EV/FCF ratio of 19.21.

EV / Earnings	20.34
EV / Sales	2.14
EV / EBITDA	10.58
EV / EBIT	13.90
EV / FCF	19.21

Financial Position

The company has a current ratio of 1.85, with a Debt / Equity ratio of 0.22.

Current Ratio	1.85
Quick Ratio	0.95
Debt / Equity	0.22
Debt / EBITDA	1.18
Debt / FCF	2.15
Interest Coverage	12.29

Financial Efficiency

Return on equity (ROE) is 10.38% and return on invested capital (ROIC) is 7.66%.

Return on Equity (ROE)	10.38%
Return on Assets (ROA)	6.25%
Return on Invested Capital (ROIC)	7.66%
Return on Capital Employed (ROCE)	13.59%
Revenue Per Employee	11.74M
Profits Per Employee	1.24M
Employee Count	27,707
Asset Turnover	0.65
Inventory Turnover	1.27

Taxes

In the past 12 months, BOM:524804 has paid 15.97 billion in taxes.

Income Tax	15.97B
Effective Tax Rate	31.83%

Stock Price Statistics

The stock price has decreased by -2.73% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-2.73%
50-Day Moving Average	1,149.10
200-Day Moving Average	1,135.02
Relative Strength Index (RSI)	58.57
Average Volume (20 Days)	29,816

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:524804 had revenue of INR 325.14 billion and earned 34.22 billion in profits. Earnings per share was 58.93.

Revenue	325.14B
Gross Profit	187.35B
Operating Income	50.35B
Pretax Income	50.18B
Net Income	34.22B
EBITDA	65.32B
EBIT	50.35B
Earnings Per Share (EPS)	58.93

Balance Sheet

The company has 88.92 billion in cash and 77.95 billion in debt, giving a net cash position of 10.98 billion.

Cash & Cash Equivalents	88.92B
Total Debt	77.95B
Net Cash	10.98B
Net Cash Per Share	n/a
Equity (Book Value)	350.34B
Book Value Per Share	603.40
Working Capital	131.48B

Cash Flow

In the last 12 months, operating cash flow was 61.57 billion and capital expenditures -25.34 billion, giving a free cash flow of 36.23 billion.

Operating Cash Flow	61.57B
Capital Expenditures	-25.34B
Free Cash Flow	36.23B
FCF Per Share	n/a

Margins

Gross margin is 57.62%, with operating and profit margins of 15.48% and 10.53%.

Gross Margin	57.62%
Operating Margin	15.48%
Pretax Margin	15.43%
Profit Margin	10.53%
EBITDA Margin	20.09%
EBIT Margin	15.48%
FCF Margin	11.14%

Dividends & Yields

This stock pays an annual dividend of 4.00, which amounts to a dividend yield of 0.33%.

Dividend Per Share	4.00
Dividend Yield	0.33%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	6.80%
Buyback Yield	0.58%
Shareholder Yield	0.91%
Earnings Yield	4.84%
FCF Yield	5.12%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on July 20, 2015. It was a forward split with a ratio of 2.

Last Split Date	Jul 20, 2015
Split Type	Forward
Split Ratio	2

Scores

Altman Z-Score	n/a
Piotroski F-Score	7